Clinical Trial Coverage Denied? How to Appeal

Participating in a clinical trial can give patients access to promising new therapies, contribute to medical science, and in many cases represent the best available treatment option — particularly for cancer patients who have exhausted standard-of-care options. Yet insurance companies frequently deny coverage for costs associated with clinical trial participation, sometimes in direct violation of federal law. If your insurer has denied coverage for routine care costs during a clinical trial, this guide explains your legal rights and how to build a successful appeal.

Why Insurers Deny Clinical Trial Coverage

Understanding the specific basis for a clinical trial coverage denial is essential before you can challenge it effectively.

Misclassifying routine costs as "experimental" is the most common and most legally vulnerable denial ground. Insurers sometimes deny all costs associated with a clinical trial by labeling them experimental — when in fact federal law requires coverage of the routine patient care costs you would incur regardless of trial participation. This misclassification is prohibited under ACA Section 2709 for all non-grandfathered health plans.

Arguing the trial is not "qualified" allows insurers to deny coverage by claiming the trial does not meet ACA Section 2709 criteria. A qualifying trial must be federally funded (NIH, NCI, CMS, Department of Defense, VA, or other federal agency), conducted under an FDA Investigational New Drug (IND) application, or exempt from IND requirements. The vast majority of NCI-funded and major academic medical center trials qualify. Your trial's principal investigator can provide written confirmation of the trial's qualifying status.

Claiming the specific cancer type or treatment is excluded from the plan's coverage for clinical trials. Some plans attempt to limit clinical trial coverage to specific cancer types or treatment categories. Review your plan documents carefully — ACA Section 2709 prohibitions on discrimination apply broadly and cannot be circumvented by narrow plan language.

Denying coverage for standard services billed alongside trial-specific costs occurs when insurers deny a standard laboratory test, imaging study, or physician consultation because it was billed on the same day as a research procedure. The billing of trial-specific costs alongside routine costs does not eliminate the coverage obligation for the routine costs.

Grandfathered plan exemption claims are worth scrutinizing. Grandfathered plans under the ACA are exempt from Section 2709, but many plans that claimed grandfathered status have since lost that status due to changes in cost-sharing or benefits. Your insurer should be able to confirm whether your plan is grandfathered — if it is not, Section 2709 applies.

How to Appeal a Clinical Trial Coverage Denial

Step 1: Establish Your Legal Rights Under ACA Section 2709

The first element of your appeal is establishing that ACA Section 2709 applies to your plan. For non-grandfathered plans with plan years beginning on or after January 1, 2014, the law mandates: coverage of routine patient care costs in qualified clinical trials; a prohibition on denying or limiting routine care coverage based solely on trial participation; and a prohibition on discrimination against trial participants. Cite 42 U.S.C. § 300gg-8 and the implementing regulations at 45 C.F.R. § 147.140 in your appeal letter.

Step 2: Obtain Qualified Trial Documentation from Your Principal Investigator

Your clinical trial's principal investigator (PI) or the trial's coordinating institution can provide a letter confirming: that the trial meets ACA Section 2709 qualifying criteria; the federal funding source or FDA IND application number; the trial's NCI or ClinicalTrials.gov registration number; and a description of which costs in your claim are routine patient care costs versus trial-specific costs. This letter is essential — without it, the insurer can continue to dispute whether the trial qualifies.

Step 3: Document Which Costs Are Routine vs. Trial-Specific

Prepare a detailed breakdown distinguishing routine patient care costs (covered under ACA law) from trial-specific costs (not required to be covered). Routine costs include: standard physician visits, standard lab work (CBC, metabolic panels, tumor markers with ICD-10 codes relevant to your cancer diagnosis such as C50.x for breast cancer or C34.x for lung cancer), standard imaging (CT, MRI, PET scans ordered for clinical management), and treatment of side effects arising from the trial intervention. Trial-specific costs include the investigational drug itself (provided by the sponsor), additional research-only procedures, and data collection activities performed solely for research purposes.

Step 4: Submit Your Internal Appeal Citing Federal Law

File a written appeal that: cites ACA Section 2709 (42 U.S.C. § 300gg-8) and the implementing regulations; identifies your plan as non-grandfathered; attaches the PI's qualification letter; provides the routine vs. trial-specific cost breakdown; and includes your clinical records documenting the diagnoses (with ICD-10 codes) and the standard-of-care nature of the routine services. State explicitly that your insurer's denial of routine care costs in a qualified clinical trial is prohibited by federal law.

Step 5: File a Complaint with CMS or Your State Insurance Commissioner

If your insurer denies an internal appeal based on Section 2709 grounds, file a complaint with the Centers for Medicare and Medicaid Services (CMS) through the HealthCare.gov complaint portal, or with your state insurance commissioner. CMS has authority to enforce ACA Section 2709 compliance. State regulators may also have authority over state-regulated plans.

Step 6: Request Independent External Independent Review: Complete Guide" class="auto-link">External Review

You have the right to independent external review of any clinical trial coverage denial. An IRO reviewing a clinical trial appeal will evaluate whether the trial qualifies under Section 2709 and whether the denied costs are routine patient care costs. External reviewers with oncology expertise regularly overturn these denials when the documentation establishes that federal law requires coverage. External review is free to you and produces a binding decision.

What to Include in Your Appeal

• The insurer's denial letter identifying the specific basis for denial (experimental classification, non-qualified trial, or other stated reason)
• Written letter from the clinical trial's principal investigator confirming qualifying status under ACA Section 2709, including the federal funding source and ClinicalTrials.gov registration number
• Detailed breakdown of costs at issue distinguishing routine patient care costs (with applicable ICD-10 codes for your cancer diagnosis) from trial-specific research costs
• Clinical records documenting the standard-of-care nature of the routine services denied, including ordering physician notes and diagnostic reports
• Explicit citation of 42 U.S.C. § 300gg-8 and 45 C.F.R. § 147.140, with a statement that your plan is non-grandfathered

Fight Back With ClaimBack

Clinical trial coverage denials that misclassify routine costs as experimental are among the clearest violations of federal insurance law — and among the most reversible when appealed with proper documentation. The appeal must be precise: establish the trial's qualified status, document which costs are routine, and cite the federal statutory authority that requires coverage. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal